Moxifloxacin solution for infusions, 400 mg/250 ml, 250 ml each;Chlorpromazine, solution for injection, 25 mg/ml, 2 ml each;Amiodarone, tablets, 200 mg each;Bisoprolol tablets 10 mg each;Acetazolamide, tablets, 250 mg each;Docetaxel, concentrate, 20 mg/ml, 4 ml each;Drotaverin solution for injections 20 mg/ml, 2 ml in an ampoule;Ibuprofen tablets/capsules of 400 mg;Ibuprofen tablets/capsules of 200 mg;Captopril, tablets, 25 mg each;Carbamazepine 200 mg tablets;Quetiapine, film-coated tablets, 10
By: Galina Bordyliak๐ UkraineOpen
Key Information
| Reference | GB-UA-2026-11-18-013874-a |
|---|
| Deadline | Nov 23, 2026 12:00 AM |
|---|
| Estimated Value | UAH 96,840,093.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 80100, Ukraine, Lviv region, Sheptytskyi, st.Ivasyuka, building 2 |
|---|
| Published | Nov 18, 2026 |
|---|
Description
Moxifloxacin solution for infusions, 400 mg/250 ml, 250 ml each;Chlorpromazine, solution for injection, 25 mg/ml, 2 ml each;Amiodarone, tablets, 200 mg each;Bisoprolol tablets 10 mg each;Acetazolamide...
Full details are available after unlocking this tender.